CCSS Board Suspends Three Witnesses in Barrenador Case
Translated from Spanish and summarized by DistantNews. Read the original for the full story.
At a glance
- The Board of Directors of the CCSS has suspended three key financial personnel in the Barrenador case.
- The suspended individuals include the financial manager, financial director, and head of cost accounting.
- Their suspension follows findings of a "lack of opportunity" in submitting annual cost reports for medical services.
The Board of Directors of the Costa Rican Social Security Fund (CCSS) has taken disciplinary action, suspending three key financial witnesses involved in the ongoing Barrenador case. The individuals suspended are Gustavo Picado, the financial manager; Andrey Sรกnchez, the financial director; and Azyhadde Picado, the head of the cost accounting area.
This decision comes after a factual review revealed what the board termed a "lack of opportunity" in the timely submission of annual cost reports for medical services. The precise implications of this "lack of opportunity" are not detailed, but it suggests potential procedural failures or delays in financial reporting that are relevant to the investigation.
The Barrenador case itself appears to involve financial irregularities or mismanagement within the CCSS, a critical public institution responsible for social security and healthcare in Costa Rica. The suspension of these witnesses indicates their potential importance to the investigation and the board's efforts to ensure accountability.
Fernanda Matarrita Chaves, a journalist with experience in education and health reporting, covered this story. Her work has previously been recognized with national and regional awards for content related to children, adolescents, and health journalism, suggesting a focus on transparency and public interest in her reporting.
Originally published by La Naciรณn in Spanish. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.